The recent reverse takeover is great news for the future of the shareholders, who are in it for the the long term. Sales can flow through to the new Canadian company from the US immediately after Highbrid Lab is listed on the CSE.
As the dowmrampers are so right about, the fluff and mirrors will be poured onto the North American investors and it will be wonderful for us investors, as Psychedelic Companies who are in clinical trials already are going great guns.
If you have not DYOR on Psychedelics and Mental Health and this company, please sell.
I actually prefer the CPH share price to drop even more so I will end up with many more CSE shares.
So keep the down ramping going.Being not a shorter or short term longer, this is a no brainer investment.
Major CPH holders are wanting to have a strong share price so they can get richer and for me riding their fluff and mirrors to a great retirement.
So if CPH drops I’m happy if it goes up I’m content.
Really can’t lose on this one.
CPH Price at posting:
14.0¢ Sentiment: None Disclosure: Held
